However, there is a small percentage of patients in which ICI can still work despite of APP alterations, suggesting that, especially for tumors with high mutation burden, antigen presentation is not completely abolished and can represent an Achilles’ heel of the tumour (80). This evidence concerns the gene APP and neoplasm.